Added value of PCR-testing for confirmation of invasive meningococcal disease in England

Journal of Infection

Volumn 67, Issue 5, 2013, Pages 385-390

  Heinsbroek, Ellen ^a,b   Ladhani, Shamez ^b   Gray, Steve ^c   Guiver, Malcolm ^c   Kaczmarski, Ed ^c   Borrow, Ray ^c   Ramsay, Mary ^b  

^a EUROPEAN CENTRE FOR DISEASE PREVENTION AND CONTROL ECDC   (Sweden)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

^c MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

Bacterial infections; Diagnosis; Invasive meningococcal disease; Meningococcal infections; Neisseria meningitidis; Polymerase chain reaction; Surveillance

Indexed keywords

ARTICLE; BACTERIUM ISOLATE; BLOOD CULTURE; DIAGNOSTIC VALUE; HUMAN; INVASIVE MENINGOCOCCAL DISEASE; MAJOR CLINICAL STUDY; MENINGOCOCCOSIS; NEISSERIA MENINGITIDIS; NONHUMAN; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; UNITED KINGDOM; VALIDITY;

BACTERIAL INFECTIONS; DIAGNOSIS; INVASIVE MENINGOCOCCAL DISEASE; MENINGOCOCCAL INFECTIONS; NEISSERIA MENINGITIDIS; POLYMERASE CHAIN REACTION; SURVEILLANCE;

ADOLESCENT; ADULT; AGED; CHI-SQUARE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; ENGLAND; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MENINGOCOCCAL INFECTIONS; MIDDLE AGED; MOLECULAR TYPING; NEISSERIA MENINGITIDIS; POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84884703665     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2013.06.007     Document Type: Article

References (15)

1. Halperin S.A., Bettinger J.A., Greenwood B., Harrison L.H., Jelfs J., Ladhani S.N., et al. The changing and dynamic epidemiology of meningococcal disease. Vaccine 2012, 30:B26-B36. 10.1016/j.vaccine.2011.12.032.
2. Ladhani S.N., Flood J.S., Ramsay M.E., Campbell H., Gray S.J., Kaczmarski E.B., et al. Invasive meningococcal disease in England and Wales: implications for the introduction of new vaccines. Vaccine 2012, 30:3710-3716. 10.1016/j.vaccine.2012.03.011.
3. Health Protection Agency Meningococcal disease - epidemiological data 2012, London, [cited 19 Oct 2012]. http://www.hpa.org.uk/Topics/InfectiousDiseases/InfectionsAZ/MeningococcalDisease/EpidemiologicalData/.
4. Gray S.J., Trotter C.L., Ramsay M.E., Guiver M., Fox A.J., Borrow R., et al. Epidemiology of meningococcal disease in England and Wales 1993/94 to 2003/04: contribution and experiences of the Meningococcal Reference Unit. J Med Microbiol 2006, 55:887-896.
5. Kaczmarski E., Ragunathan P., Marsh J., Gray S., Guiver M. Creating a national service for the diagnosis of meningococcal disease by polymerase chain reaction. Commun Dis Public Health 1998, 1:54-56.
6. Bryant P.A., Li H.Y., Zaia A., Griffith J., Hogg G., Curtis N., et al. Prospective study of a real-time PCR that is highly sensitive, specific, and clinically useful for diagnosis of meningococcal disease in children. J Clin Microbiol 2004, 42:2919-2925.
7. Munoz-Almagro C., Rodriguez-Plata M., Marin S., Esteva C., Esteban E., Gene A., et al. Polymerase chain reaction for diagnosis and serogrouping of meningococcal disease in children. Diagn Microbiol Infect Dis 2009, 63:148-154. 10.1016/j.diagmicrobio.2008.10.008.
8. National Institute for Health and Clinical Excellence Bacterial meningitis and meningococcal septicaemia: management of bacterial meningitis and meningococcal septicaemia in children and young people younger than 16 years in primary and secondary care. NICE clinical guideline 102 2010, [cited 6 May 2013]. http://www.nice.org.uk/nicemedia/live/13027/49339/49339.pdf.
9. Reacher M.H., Shah A., Livermore D.M., Wale M.C., Graham C., Johnson A.P., et al. Bacteraemia and antibiotic resistance of its pathogens reported in England and Wales between 1990 and 1998: trend analysis. BMJ 2000, 320:213-216.
10. The Stationery Office Limited (TSO) Health protection (notification) regulations 2010 2010, London, [cited 8 Jan 2013]. http://www.legislation.gov.uk/uksi/2010/659/pdfs/uksi_20100659_en.pdf.
11. Drew R.J., Ó Maoldomhnaigh C., Gavin P.J., O' Sullivan N., Butler K.M., Cafferkey M. The impact of meningococcal polymerase chain reaction testing on laboratory confirmation of invasive meningococcal disease. Pediatr Infect Dis J 2012, 31:316-318. 10.1097/INF.0b013e318241f824.
12. Bronska E., Kalmusova J., Dzupova O., Maresova V., Kriz P., Benes J. Dynamics of PCR-based diagnosis in patients with invasive meningococcal disease. Clin Microbiol Infect 2006, 12:137-141.
13. Vogel U., Stefanelli P., Vazquez J., Taha M.-K., Claus H., Donnelly J. The use of vaccine antigen characterization, for example by MATS, to guide the introduction of meningococcus B vaccines. Vaccine 2012, 30:B73-B77. 10.1016/j.vaccine.2011.12.061.
14. Perea-Milla E., Olalla J., Sánchez-Cantalejo E., Martos F., Matute-Cruz P., Carmona-López G., et al. Pre-hospital antibiotic treatment and mortality caused by invasive meningococcal disease, adjusting for indication bias. BMC Public Health 2009, 9:95. 10.1186/1471-2458-9-95.
15. Darton T., Guiver M., Naylor S., Jack D.L., Kaczmarski E.B., Borrow R., et al. Severity of meningococcal disease associated with genomic bacterial load. Clin Infect Dis 2009, 48:587-594. 10.1086/596707.